Bavarian Nordic awarded $100M smallpox vaccine contract by U.S. government

Bavarian Nordic secured a sole source contract from BARDA for freeze-dried IMVAMUNE smallpox vaccine, with an initial base award of USD 100 million for bulk manufacturing and potential total value exceeding USD 539 million.

“The initial award in the contract calls for the manufacturing and storage of USD 100 million of IMVAMUNE bulk.”biospace.com

• 1 source
• biospace.comBavarian Nordic Secures Contract Award For Supply Of Freeze-Dried IMVAMUNE Smallpox Vaccine To The U.S. Government - BioSpaceHeather McKenzieSep 28, 2017

Summarized from public sources; check the original articles before acting on it.